Hideki Kasuya
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Comparing traditional and online problem-based learning in child and adolescent psychiatry in Nagoya: a novel statistical approach in Japanese educational settings.
Journal: BMC medical education
Published: January 29, 2026
Influence of learning activities and background characteristics on pharmacology exam success in second-year medical students at a French university: the Pharmaquest study.
Journal: BMC medical education
Published: December 17, 2025
The Nagoya University and the University of Adelaide Joint PhD Degree Program in Medicine - A Program of Opportunity.
Journal: Advances in medical education and practice
Published: March 14, 2025
Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antigen expression.
Journal: Cancer immunology, immunotherapy : CII
Published: September 19, 2024
STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy.
Journal: Molecular oncology
Published: October 12, 2023
The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies.
Journal: International journal of molecular sciences
Published: August 01, 2023
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model.
Journal: Scientific reports
Published: July 22, 2022
An international medical education perspective on training in child and adolescent psychiatry.
Journal: Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists
Published: February 03, 2022
Problem-Based Learning in Child and Adolescent Psychiatry: A Perspective from Japan.
Journal: Advances in medical education and practice
Published: August 23, 2021
Continuing medical education during pandemic waves of COVID-19: Consensus from medical faculties in Asia, Australia and Europe.
Journal: MedEdPublish (2016)
Published: March 08, 2021
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model.
Journal: Nagoya journal of medical science
Published: November 16, 2020
Last Updated: 09/26/2026